The Grünenthal Group
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.
We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.
New exclusive licence agreement
Agreement underpins Grünenthal’s strategy to strengthen its portfolio for the European hospital market
The Grünenthal Group announced an exclusive license and supply agreement with Adhesys Medical Inc., USA, on the commercialization of an innovative topical skin adhesive.
With this agreement, Grünenthal acquires the exclusive distribution rights for the EU and Latin American markets.
Both companies pursue the common objective to launch a medical device that meets highest standards.